# STX1A

## Overview
STX1A is a gene that encodes the protein syntaxin 1A, a member of the SNARE (Soluble NSF Attachment Protein Receptor) family, which plays a pivotal role in synaptic vesicle fusion and neurotransmitter release at neuronal synapses. Syntaxin 1A is a transmembrane protein characterized by several structural domains, including an N-peptide, an Habc domain, an H3 helix (SNARE domain), and a transmembrane region, all of which contribute to its function in synaptic transmission (Vardar2021Reexamination). The protein is integral to the formation of the SNARE complex, interacting with other SNARE proteins such as SNAP25 and VAMP2 to mediate membrane fusion events essential for neuronal communication (Tebbe2024The). Variants in the STX1A gene have been linked to various neurodevelopmental disorders, including epilepsy and autism, highlighting its clinical significance in neurological health (Luppe2022Heterozygous).

## Structure
Syntaxin-1A (STX1A) is a protein involved in synaptic vesicle fusion and neurotransmitter release. Its molecular structure includes several distinct domains. The primary structure of STX1A consists of a sequence of amino acids that form specific domains: a short N-peptide, an Habc domain, an H3 helix (SNARE domain), and a transmembrane region (TMR) (Vardar2021Reexamination). The Habc domain is composed of three helices (Ha, Hb, and Hc) and is essential for neurotransmitter release and neuronal viability (Vardar2021Reexamination). The SNARE domain, also known as the H3 helix, is crucial for forming the SNARE complex, which facilitates membrane fusion (Vardar2021Reexamination).

The juxtamembrane domain (JMD) and transmembrane domain (TMD) of STX1A play significant roles in vesicle fusion. The JMD is unstructured and influences the palmitoylation of the TMD, a post-translational modification critical for spontaneous neurotransmitter release (Vardar2022Syntaxin1A). Palmitoylation occurs on cysteine residues within the TMD, affecting the protein's function in synaptic transmission (Vardar2022Syntaxin1A).

STX1A has several splice variant isoforms, which can affect its function and localization (Vardar2022Syntaxin1A). These structural features and modifications underscore the complexity and functional importance of STX1A in neuronal communication.

## Function
Syntaxin 1A (STX1A) is a crucial component of the SNARE complex, which mediates membrane fusion events essential for neurotransmitter release at neuronal synapses. In healthy human cells, STX1A interacts with synaptosomal-associated protein 25 (SNAP25) and vesicle-associated membrane protein 2 (VAMP2) to facilitate the fusion of synaptic vesicles with the presynaptic membrane, a process vital for synaptic transmission and neuronal communication (Tebbe2024The). 

STX1A's function is modulated by its structural domains, including the transmembrane domain (TMD) and juxtamembrane domain (JMD). The TMD is palmitoylated, which lowers the energy barrier for membrane fusion, enhancing spontaneous vesicle fusion and synchronizing Ca2+-evoked release (Vardar2022Syntaxin1A). The JMD influences the palmitoylation of the TMD, affecting spontaneous neurotransmitter release and vesicle priming through electrostatic interactions with the plasma membrane (Vardar2022Syntaxin1A). 

STX1A also plays a role in regulating synaptic vesicle endocytosis through SUMOylation, which modulates its interaction with other SNARE proteins, maintaining the balance of synaptic vesicle endo/exocytosis (Craig2015SUMOylation). This regulatory mechanism ensures efficient neurotransmitter release and synaptic function.

## Clinical Significance
Mutations in the STX1A gene are associated with a range of neurodevelopmental disorders. Variants in STX1A can lead to intellectual disability, autism, and epilepsy. Missense variants are particularly linked to epileptic encephalopathy, as they disrupt the interaction between STX1A and STXBP1, a critical component of the SNARE complex involved in synaptic vesicle exocytosis (Luppe2022Heterozygous). In contrast, in-frame deletions or homozygous splice variants are associated with intellectual disability and autistic behavior without epilepsy (Luppe2022Heterozygous).

Alterations in STX1A expression have been implicated in high-functioning autism (HFA). Elevated STX1A mRNA expression has been observed in the lymphocytes of drug-naive HFA patients, suggesting a role in the pathophysiology of autism, potentially through its influence on the serotonergic system (Nakamura2008Genetic).

STX1A variants also play a role in glucose metabolism disorders. The −352 A>T variant in the STX1A promoter is associated with impaired glucose metabolism in obese populations, potentially affecting insulin secretion and increasing the risk of type 2 diabetes (Romeo2007Search).

## Interactions
Syntaxin 1A (STX1A) is a key component of the SNARE complex, which is essential for synaptic vesicle exocytosis. It interacts with several proteins to facilitate neurotransmitter release. STX1A forms a complex with SNAP-25 and VAMP2, which is crucial for vesicle fusion at the synaptic membrane (Misura2000Threedimensional). It also interacts with Munc18-1 (nSec1), which binds to the Habc and H3 regions of STX1A, playing a regulatory role in membrane trafficking and vesicle fusion (Misura2000Threedimensional).

STX1A interacts with JNK2, a protein kinase, at its N-terminal sequence. This interaction is involved in NMDA receptor-dependent glutamate release. A peptide named JGRi1 can disrupt this interaction, reducing NMDA-evoked neurotransmitter release, which has implications for conditions involving excitotoxicity (Marcelli2019The).

STX1A also participates in interactions with synaptic proteins like STXBP1 and SNAP25, as identified through cross-linking mass spectrometry. These interactions are important for the structural integrity and function of the SNARE complex in presynaptic vesicle fusion (GonzalezLozano2020Stitching). Variants in STX1A can affect its interaction with STXBP1, leading to neurodevelopmental disorders (Luppe2022Heterozygous).


## References


[1. (Nakamura2008Genetic) Kazuhiko Nakamura, Ayyappan Anitha, Kazuo Yamada, Masatsugu Tsujii, Yoshimi Iwayama, Eiji Hattori, Tomoko Toyota, Shiro Suda, Noriyoshi Takei, Yasuhide Iwata, Katsuaki Suzuki, Hideo Matsuzaki, Masayoshi Kawai, Yoshimoto Sekine, Kenji J. Tsuchiya, Gen-ichi Sugihara, Yasuomi Ouchi, Toshiro Sugiyama, Takeo Yoshikawa, and Norio Mori. Genetic and expression analyses reveal elevated expression of syntaxin 1a ( stx1a) in high functioning autism. The International Journal of Neuropsychopharmacology, 11(08):1073, July 2008. URL: http://dx.doi.org/10.1017/s1461145708009036, doi:10.1017/s1461145708009036. This article has 63 citations.](https://doi.org/10.1017/s1461145708009036)

[2. (Vardar2022Syntaxin1A) Gülçin Vardar, Andrea Salazar-Lázaro, Sina Zobel, Thorsten Trimbuch, and Christian Rosenmund. Syntaxin-1a modulates vesicle fusion in mammalian neurons via juxtamembrane domain dependent palmitoylation of its transmembrane domain. eLife, May 2022. URL: http://dx.doi.org/10.7554/elife.78182, doi:10.7554/elife.78182. This article has 19 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.7554/elife.78182)

[3. (Craig2015SUMOylation) Tim J. Craig, Dina Anderson, Ashley J. Evans, Fatima Girach, and Jeremy M. Henley. Sumoylation of syntaxin1a regulates presynaptic endocytosis. Scientific Reports, December 2015. URL: http://dx.doi.org/10.1038/srep17669, doi:10.1038/srep17669. This article has 46 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/srep17669)

[4. (Misura2000Threedimensional) Kira M. S. Misura, Richard H. Scheller, and William I. Weis. Three-dimensional structure of the neuronal-sec1–syntaxin 1a complex. Nature, 404(6776):355–362, March 2000. URL: http://dx.doi.org/10.1038/35006120, doi:10.1038/35006120. This article has 621 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/35006120)

[5. (GonzalezLozano2020Stitching) M. A. Gonzalez-Lozano, F. Koopmans, P. F. Sullivan, J. Protze, G. Krause, M. Verhage, K. W. Li, F. Liu, and A. B. Smit. Stitching the synapse: cross-linking mass spectrometry into resolving synaptic protein interactions. Science Advances, February 2020. URL: http://dx.doi.org/10.1126/sciadv.aax5783, doi:10.1126/sciadv.aax5783. This article has 76 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1126/sciadv.aax5783)

[6. (Luppe2022Heterozygous) Johannes Luppe, Heinrich Sticht, François Lecoquierre, Alice Goldenberg, Kathleen M. Gorman, Ben Molloy, Emanuele Agolini, Antonio Novelli, Silvana Briuglia, Outi Kuismin, Carlo Marcelis, Antonio Vitobello, Anne-Sophie Denommé-Pichon, Sophie Julia, Johannes R. Lemke, Rami Abou Jamra, and Konrad Platzer. Heterozygous and homozygous variants in stx1a cause a neurodevelopmental disorder with or without epilepsy. European Journal of Human Genetics, 31(3):345–352, December 2022. URL: http://dx.doi.org/10.1038/s41431-022-01269-6, doi:10.1038/s41431-022-01269-6. This article has 8 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/s41431-022-01269-6)

[7. (Romeo2007Search) S Romeo, F Sentinelli, M G Cavallo, F Leonetti, M Fallarino, S Mariotti, and M G Baroni. Search for genetic variants of the syntaxin 1a (stx1a) gene: the −352 a&gt;t variant in the stx1a promoter associates with impaired glucose metabolism in an italian obese population. International Journal of Obesity, 32(3):413–420, October 2007. URL: http://dx.doi.org/10.1038/sj.ijo.0803743, doi:10.1038/sj.ijo.0803743. This article has 26 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/sj.ijo.0803743)

[8. (Marcelli2019The) Serena Marcelli, Filomena Iannuzzi, Elena Ficulle, Dalila Mango, Stefano Pieraccini, Sara Pellegrino, Massimo Corbo, Maurizio Sironi, Anna Pittaluga, Robert Nisticò, and Marco Feligioni. The selective disruption of presynaptic jnk2/stx1a interaction reduces nmda receptor-dependent glutamate release. Scientific Reports, May 2019. URL: http://dx.doi.org/10.1038/s41598-019-43709-2, doi:10.1038/s41598-019-43709-2. This article has 11 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41598-019-43709-2)

[9. (Vardar2021Reexamination) Gülçin Vardar, Andrea Salazar-Lázaro, Marisa Brockmann, Marion Weber-Boyvat, Sina Zobel, Victor Wumbor-Apin Kumbol, Thorsten Trimbuch, and Christian Rosenmund. Reexamination of n-terminal domains of syntaxin-1 in vesicle fusion from central murine synapses. eLife, August 2021. URL: http://dx.doi.org/10.7554/elife.69498, doi:10.7554/elife.69498. This article has 17 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.7554/elife.69498)

[10. (Tebbe2024The) Lars Tebbe, Mashal Kakakhel, Muayyad R. Al-Ubaidi, and Muna I. Naash. The role of syntaxins in retinal function and health. Frontiers in Cellular Neuroscience, May 2024. URL: http://dx.doi.org/10.3389/fncel.2024.1380064, doi:10.3389/fncel.2024.1380064. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fncel.2024.1380064)